Cargando…

Potential Role of Antioxidants as Adjunctive Therapy in Chagas Disease

Chagas disease (CD) is one of the most important neglected tropical diseases in the American continent. Host-derived nitroxidative stress in response to Trypanosoma cruzi infection can induce tissue damage contributing to the progression of Chagas disease. Antioxidant supplementation has been sugges...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sánchez-Villamil, Juana P., Bautista-Niño, Paula K., Serrano, Norma C., Rincon, Melvin Y., Garg, Nisha J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136780/ https://www.ncbi.nlm.nih.gov/pubmed/32308809 http://dx.doi.org/10.1155/2020/9081813

Ejemplares similares

Chaga mushroom triterpenoids as adjuncts to minimally invasive cancer therapies: A review
por: Plehn, Selina, et al.
Publicado: (2023)

Platelets, Macrophages, and Thromboinflammation in Chagas Disease
por: Choudhuri, Subhadip, et al.
Publicado: (2022)

Oxidative Stress in Chagas Disease
por: Gupta, Shivali, et al.
Publicado: (2009)

Call for Consensus in the Evaluation of Circulating Matrix Metalloproteinases in Chagas Disease
por: Bautista-López, Norma L., et al.
Publicado: (2022)

Innate Immune Responses and Antioxidant/Oxidant Imbalance Are Major Determinants of Human Chagas Disease
por: Dhiman, Monisha, et al.
Publicado: (2013)

Circulating MicroRNAs and myocardial involvement severity in chronic Chagas cardiomyopathy
por: Gómez-Ochoa, Sergio Alejandro, et al.
Publicado: (2022)

Views on antioxidant mouthwashes as adjunct in periodontal therapy
por: Kumar, Karthikeyan Murthy, et al.
Publicado: (2020)

Potential Role of Glutathione Antioxidant Pathways in the Pathophysiology and Adjunct Treatment of Psychiatric Disorders
por: Poladian, Nicole, et al.
Publicado: (2023)

Sirtuin Control of Mitochondrial Dysfunction, Oxidative Stress, and Inflammation in Chagas Disease Models
por: Wan, Xianxiu, et al.
Publicado: (2021)

The role of berberine in Covid-19: potential adjunct therapy
por: Babalghith, Ahmad O., et al.
Publicado: (2022)

The role of oxidative stress in neurodegenerative diseases and potential antioxidant therapies
por: Sienes Bailo, Paula, et al.
Publicado: (2022)

Antigenicity and Diagnostic Potential of Vaccine Candidates in Human Chagas Disease
por: Gupta, Shivali, et al.
Publicado: (2013)

The Use of Antioxidants as Potential Co-Adjuvants to Treat Chronic Chagas Disease
por: Maldonado, Edio, et al.
Publicado: (2021)

Antioxidant therapy as monotherapy or as an adjunct to treatment of periodontal diseases
por: Mathur, Aditi, et al.
Publicado: (2013)

A model of metformin mitochondrial metabolism in metachromatic leukodystrophy: first description of human Schwann cells transfected with CRISPR-Cas9
por: Sanchez-Álvarez, Nayibe Tatiana, et al.
Publicado: (2022)

Barriers to Diagnosis Access for Chagas Disease in Colombia
por: Olivera, Mario Javier, et al.
Publicado: (2018)

Manganese superoxide dismutase deficiency exacerbates the mitochondrial ROS production and oxidative damage in Chagas disease
por: Wen, Jake J., et al.
Publicado: (2018)

Cardiac-Oxidized Antigens Are Targets of Immune Recognition by Antibodies and Potential Molecular Determinants in Chagas Disease Pathogenesis
por: Dhiman, Monisha, et al.
Publicado: (2012)

Trypanosoma cruzi Induces the PARP1/AP-1 Pathway for Upregulation of Metalloproteinases and Transforming Growth Factor β in Macrophages: Role in Cardiac Fibroblast Differentiation and Fibrosis in Chagas Disease
por: Choudhuri, Subhadip, et al.
Publicado: (2020)

Ozone therapy: a potential therapeutic adjunct for improving female reproductive health
por: Merhi, Zaher, et al.
Publicado: (2019)

Virotherapy as Potential Adjunct Therapy for Graft-Vs-Host Disease
por: Villa, Nancy Y., et al.
Publicado: (2018)

Antioxidant effect of Morus nigra on Chagas disease progression
por: Montenote, Michelly Cristina, et al.
Publicado: (2017)

Adjunctive therapy in Parkinson’s disease: the role of rasagiline
por: Gaines, Kathryn D, et al.
Publicado: (2012)

Cell Therapy in Chagas Disease
por: Campos de Carvalho, Antonio C., et al.
Publicado: (2009)

Potential Utility of Protein Targets of Cysteine-S-Nitrosylation in Identifying Clinical Disease Status in Human Chagas Disease
por: Zago, Maria Paola, et al.
Publicado: (2019)

Prevalence of Neutralizing Antibodies against Adeno-Associated Virus Serotypes 1, 2, and 9 in Non-Injected Latin American Patients with Heart Failure—ANVIAS Study
por: Sierra-Delgado, Julieth A., et al.
Publicado: (2023)

PARP1 depletion improves mitochondrial and heart function in Chagas disease: Effects on POLG dependent mtDNA maintenance
por: Wen, Jake Jianjun, et al.
Publicado: (2018)

Determination of Anti-Adeno-Associated Viral Vector Neutralizing Antibodies in Patients With Heart Failure in the Cardiovascular Foundation of Colombia (ANVIAS): Study Protocol
por: Rincon, Melvin Y, et al.
Publicado: (2016)

Role of Lactate Measurement in Flap Monitoring: An Useful Adjunct
por: Singh, Karan, et al.
Publicado: (2023)

PARP1-cGAS-NF-κB pathway of proinflammatory macrophage activation by extracellular vesicles released during Trypanosoma cruzi infection and Chagas disease
por: Choudhuri, Subhadip, et al.
Publicado: (2020)

Potentiating the effects of radiotherapy in rectal cancer: the role of aspirin, statins and metformin as adjuncts to therapy
por: Gash, K J, et al.
Publicado: (2017)

The Potential Use of Propolis as an Adjunctive Therapy in Breast Cancers
por: Hermansyah, Dedy, et al.
Publicado: (2022)

Insights into Chagas treatment based on the potential of bacteriocin AS-48
por: Martín-Escolano, Rubén, et al.
Publicado: (2019)

Chagas Disease-Related Mortality in Spain, 1997 to 2018
por: Ramos-Rincon, Jose-Manuel, et al.
Publicado: (2021)

Chagas disease-related mortality in Colombia from 1979 to 2018: temporal and spatial trends.
por: Olivera, Mario Javier, et al.
Publicado: (2021)

Role of PPARs in Trypanosoma cruzi Infection: Implications for Chagas Disease Therapy
por: Hovsepian, Eugenia, et al.
Publicado: (2012)

Ecologic Niche Modeling and Potential Reservoirs for Chagas Disease, Mexico.
por: Peterson, A. Townsend, et al.
Publicado: (2002)

MnSOD(tg) Mice Control Myocardial Inflammatory and Oxidative Stress and Remodeling Responses Elicited in Chronic Chagas Disease
por: Dhiman, Monisha, et al.
Publicado: (2013)

The Role of Haptoglobin Genotypes in Chagas Disease
por: Mundaray Fernández, Ninomar, et al.
Publicado: (2014)

Considerations for and Mechanisms of Adjunct Therapy in COPD
por: Mandru, Rachana, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_etermdes5p0t8qv1f3320te503